Medical nutrition therapy for gestational diabetes mellitus in Australia : what has changed in 10 years and how does current practice compare with best practice?

Background: The present study aimed to report Australian dietetic practice regarding management of gestational diabetes mellitus (GDM) and to make comparisons with the findings from a 2009 survey of dietitians and with the Academy of Nutrition and Dietetics Evidence-Based Nutrition Practice Guidelines (NPG). Methods: Cross-sectional surveys were conducted in 2019 and 2009 of dietitians providing medical nutrition therapy (MNT) to women with GDM in Australia. The present study compares responses on demographics, dietetic assessment and interventions, and guideline use in 2019 vs. 2009. Results: In total, 149 dietitians (2019) and 220 (2009) met survey inclusion criteria. In both surveys >60% of respondents reported dietary interventions aiming for >45% energy from carbohydrate, 15%–25% energy from protein and 15%–30% energy from fat. Many variations in MNT found in 2009 continued to be evident in 2019, including the percentage of energy from carbohydrate aimed for (30%–65% in 2019 vs. 20%–75% in 2009) and the wide range in the recommended minimum daily carbohydrate intake (40–220 and 60–300 g). Few dietitians reported aiming for the NPG minimum of 175 g of carbohydrate daily in both surveys (32% in 2019 vs. 26% in 2009). There were, however, some significant increases in MNT consistent with NPG recommendations in 2019 vs. 2009, including the minimum frequency of visits provided (49%, n = 61 vs. 33%, n = 69; p < 0.001) and provision of gestational weight gain advice (59%, n = 95 vs. 40%, n = 195; p < 0.05). Conclusions: Although many dietitians continue to provide MNT consistent with existing NPG, there is a need to support greater uptake, especially for recommendations regarding carbohydrate intake

Electrophysiological and behavioral responses of female African rice gall midge, Orseolia oryzivora Harris and Gagné, to host plant volatiles

African rice gall midge, Orseolia oryzivora Harris and Gagné, is a major pest of rice in Africa. Depsite its economic importance, its chemical ecology is not well understood. Here, we assessed behavioral and electrophysiological responses of O. oryzivora to host plant volatiles. In olfactometer bioassays, mated female O. oryzivora were attracted to volatiles emitted from intact rice plants but were repelled by volatiles collected from plants infested by conspecifics. In a choice test, there was a preference for volatiles from uninfested plants over those from infested plants. Coupled gas chromatography-electroantennography analyses of panicle volatiles isolated four electrophysiologically active components: (S)-linalool, 4,8-dimethyl-1,3,7-nonatriene, (E)-caryophyllene, and (R/S)-(E)-nerolidol. A synthetic blend of volatiles at the same concentration and ratio as that from an intact plant was attractive to mated females, whereas a blend based on the ratio of volatiles from an infested plant was repellent. This suggests that O. oryzivora uses olfaction for host plant recognition. The identification of blends of volatiles emitted by plants that can both attract and repel O. oryzivora may aid the development of sustainable control measures

The first crop plant genetically engineered to release an insect pheromone for defence

Insect pheromones offer potential for managing pests of crop plants. Volatility and instability are problems for deployment in agriculture but could be solved by expressing genes for the biosynthesis of pheromones in the crop plants. This has now been achieved by genetically engineering a hexaploid variety of wheat to release (E)-β-farnesene (Eβf), the alarm pheromone for many pest aphids, using a synthetic gene based on a sequence from peppermint with a plastid targeting amino acid sequence, with or without a gene for biosynthesis of the precursor farnesyl diphosphate. Pure Eβf was produced in stably transformed wheat lines with no other detectable phenotype but requiring targeting of the gene produced to the plastid. In laboratory behavioural assays, three species of cereal aphids were repelled and foraging was increased for a parasitic natural enemy. Although these studies show considerable potential for aphid control, field trials employing the single and double constructs showed no reduction in aphids or increase in parasitism. Insect numbers were low and climatic conditions erratic suggesting the need for further trials or a closer imitation, in the plant, of alarm pheromone release

Prospects for plant defence activators and biocontrol in IPM - Concepts and lessons learnt so far

There is an urgent need to develop new interventions to manage pests because evolution of pesticide resistance and changes in legislation are limiting conventional control options for farmers. We investigated β-aminobutyric acid (BABA), jasmonic acid (JA) and fructose as possible plant defence activators against grey mould disease, . Botrytis cinerea, and root knot nematode, . Meloidogyne incognita. We also tested . Trichogramma achaeae parasitoid wasps and an antifeedant plant extract for biocontrol of the invasive tomato leafminer, . Tuta absoluta. BABA and JA enhanced resistance of tomato plants to . B. cinerea but neither treatment provided complete protection and the efficacy of treatment varied over time with BABA being more durable than JA. Efficacy was partly dependent on tomato cultivar, with some cultivars responding better to BABA treatment than others. Furthermore, treatment of tomato with BABA, JA and fructose led to partial suppression of . M. incognita egg mass development. Biocontrol agent, . T. achaeae, performance against . T. absoluta could be enhanced by adjusting the rearing conditions. Both attack rate and longevity were improved by rearing the parasitoids on . T. absoluta rather than on other insects. Finally, . Ajuga chamaepitys extract was shown to have significant antifeedant activity against . T. absoluta. Our findings suggest that there are potential new solutions for protection of crops but they are more complicated to deploy, more variable and require more biological knowledge than conventional pesticides. In isolation, they may not provide the same level of protection as pesticides but are likely to be more potent when deployed in combination in IPM strategies

High-temperature performance of ferritic steels in fireside corrosion regimes: temperature and deposits

The paper reports high temperature resistance of ferritic steels in fireside corrosion regime in terms of temperature and deposits aggressiveness. Four candidate power plant steels: 15Mo3, T22, T23 and T91 were exposed under simulated air-fired combustion environment for 1000 h. The tests were conducted at 600, 650 and 700 °C according to deposit-recoat test method. Post-exposed samples were examined via dimensional metrology (the main route to quantify metal loss), and mass change data were recorded to perform the study of kinetic behavior at elevated temperatures. Microstructural investigations using ESEM-EDX were performed in order to investigate corrosion degradation and thickness of the scales. The ranking of the steels from most to the least damage was 15Mo3 > T22 > T23 > T91 in all three temperatures. The highest rate of corrosion in all temperatures occurred under the screening deposit

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial.

BACKGROUND: Staphylococcus aureus bacteraemia is a common cause of severe community-acquired and hospital-acquired infection worldwide. We tested the hypothesis that adjunctive rifampicin would reduce bacteriologically confirmed treatment failure or disease recurrence, or death, by enhancing early S aureus killing, sterilising infected foci and blood faster, and reducing risks of dissemination and metastatic infection. METHODS: In this multicentre, randomised, double-blind, placebo-controlled trial, adults (≥18 years) with S aureus bacteraemia who had received ≤96 h of active antibiotic therapy were recruited from 29 UK hospitals. Patients were randomly assigned (1:1) via a computer-generated sequential randomisation list to receive 2 weeks of adjunctive rifampicin (600 mg or 900 mg per day according to weight, oral or intravenous) versus identical placebo, together with standard antibiotic therapy. Randomisation was stratified by centre. Patients, investigators, and those caring for the patients were masked to group allocation. The primary outcome was time to bacteriologically confirmed treatment failure or disease recurrence, or death (all-cause), from randomisation to 12 weeks, adjudicated by an independent review committee masked to the treatment. Analysis was intention to treat. This trial was registered, number ISRCTN37666216, and is closed to new participants. FINDINGS: Between Dec 10, 2012, and Oct 25, 2016, 758 eligible participants were randomly assigned: 370 to rifampicin and 388 to placebo. 485 (64%) participants had community-acquired S aureus infections, and 132 (17%) had nosocomial S aureus infections. 47 (6%) had meticillin-resistant infections. 301 (40%) participants had an initial deep infection focus. Standard antibiotics were given for 29 (IQR 18-45) days; 619 (82%) participants received flucloxacillin. By week 12, 62 (17%) of participants who received rifampicin versus 71 (18%) who received placebo experienced treatment failure or disease recurrence, or died (absolute risk difference -1·4%, 95% CI -7·0 to 4·3; hazard ratio 0·96, 0·68-1·35, p=0·81). From randomisation to 12 weeks, no evidence of differences in serious (p=0·17) or grade 3-4 (p=0·36) adverse events were observed; however, 63 (17%) participants in the rifampicin group versus 39 (10%) in the placebo group had antibiotic or trial drug-modifying adverse events (p=0·004), and 24 (6%) versus six (2%) had drug interactions (p=0·0005). INTERPRETATION: Adjunctive rifampicin provided no overall benefit over standard antibiotic therapy in adults with S aureus bacteraemia. FUNDING: UK National Institute for Health Research Health Technology Assessment

Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction, GALACTIC‐HF: baseline characteristics and comparison with contemporary clinical trials

Aims: The safety and efficacy of the novel selective cardiac myosin activator, omecamtiv mecarbil, in patients with heart failure with reduced ejection fraction (HFrEF) is tested in the Global Approach to Lowering Adverse Cardiac outcomes Through Improving Contractility in Heart Failure (GALACTIC‐HF) trial. Here we describe the baseline characteristics of participants in GALACTIC‐HF and how these compare with other contemporary trials. Methods and Results: Adults with established HFrEF, New York Heart Association functional class (NYHA) ≥ II, EF ≤35%, elevated natriuretic peptides and either current hospitalization for HF or history of hospitalization/ emergency department visit for HF within a year were randomized to either placebo or omecamtiv mecarbil (pharmacokinetic‐guided dosing: 25, 37.5 or 50 mg bid). 8256 patients [male (79%), non‐white (22%), mean age 65 years] were enrolled with a mean EF 27%, ischemic etiology in 54%, NYHA II 53% and III/IV 47%, and median NT‐proBNP 1971 pg/mL. HF therapies at baseline were among the most effectively employed in contemporary HF trials. GALACTIC‐HF randomized patients representative of recent HF registries and trials with substantial numbers of patients also having characteristics understudied in previous trials including more from North America (n = 1386), enrolled as inpatients (n = 2084), systolic blood pressure &lt; 100 mmHg (n = 1127), estimated glomerular filtration rate &lt; 30 mL/min/1.73 m2 (n = 528), and treated with sacubitril‐valsartan at baseline (n = 1594). Conclusions: GALACTIC‐HF enrolled a well‐treated, high‐risk population from both inpatient and outpatient settings, which will provide a definitive evaluation of the efficacy and safety of this novel therapy, as well as informing its potential future implementation

Solid state chemistry: an introduction. 3rd edition

Provides a solid background to a fast-changing field, and also covers areas of new innovation Uses interesting applications to put the topics presented in context Incorporates a two-color layout and a four-color section to facilitate understanding of crystal structures Contains an extensive bibliography and suggestions for further reading to expedite searching for other relevant literature Includes question and answer sets, and an accompanying solutions manual Intended for first- and second-year undergraduates, this introduction to solid state chemistry includes practical examples of applications and modern developments to offer students the opportunity to apply their knowledge in real-life situations. The third edition of Solid State Chemistry: An Introduction has been comprehensively revised and updated. Building a foundation with a thorough description of crystalline structures, the book presents a wide range of the synthetic and physical techniques used to prepare and characterize solids. Other fundamental discussions include: bonding, superconductivity, and electrochemical, magnetic, optical, and conductive properties. The authors have added sections on fuel cells and electrochromic materials; conducting organic polymers, organic superconductors, and fullerenes; mesoporous solids and ALPOs; photonics; giant magnetoresistance (GMR) and colossal magnetoresistance (CMR); and p-wave (triplet) superconductors. The book also includes a completely new chapter, which examines the solid state chemical aspects of nanoscience. Each chapter contains a set of review questions and an accompanying solutions manual is available. Solid State Chemistry: An Introduction, Third Edition is written in a clear, approachable style that enhances the material by integrating its concepts in the context of current applications and areas of promising research

Synthesis and characterisation of Cr3+-containing NASICON-related phases

Chromium-containing NASICON-related phosphates of the type Na(1+x)CrxM(2−x)P3O12) (M = Ti, Hf, Zr) have been synthesised by solid state reaction and structurally characterised by Rietveld refinement of the powder X-ray diffraction data. Materials of composition A(1+x)/2CrxZr(2−x)P3O12 (A = Cd, Ca, Sr), have also been prepared and characterised. The crystal structure of Na(1+x)CrxM(2−x)P3O12 corresponds to R-3c symmetry for x values ranging from 0.15 to 2.00, whereas compounds of composition A(1+x)/2CrxZr(2−x)P3O12 corresponding to R-3c are obtained when x ≤ 1.00 for Sr2+ and Ca2+, and x ≤ 1.50 for Cd2+. The polarizing effect of the two different metal ions A and M on the phosphorus atom and the P–O bond was studied by both 31P MAS NMR and infrared spectroscopy and shows that the electron density on the phosphorus, and thus the strength of the P–O bonds, are affected by both the interstitial (A) and the structural (M) metal ions